Latest Cancer News

FDA Approves Beleodaq for Peripheral T-cell Lymphoma (07-24-2014)
The FDA announces its approval of Beleodaq (belinostat), a histone deacetylase inhibitor for treating peripheral T-cell lymphoma (PTCL), based on the results of the BELIEF study that found an overall response... Continue Reading

HPV Testing Found to Be More Effective Than Pap Smears in Evaluating Cervical Cancer Risk (07-23-2014)
Researchers at the National Cancer Institute reported that testing for HPV (human papillomavirus) is the most effective way to determine whether a woman is at risk for developing cervical cancer in the... Continue Reading

Revlimid, Velcade, and Dexamethasone Followed by Revlimid Maintenance Appears Promising (07-22-2014)
Researchers from France recently published the preliminary results of a clinical trial evaluating chemotherapy induction and consolidation treatment with Revlimid (lenalidomide), Velcade (bortezomib),... Continue Reading

More Cancer News

Patient Resources

CoC Logo 541 ACCREDITED PROGRAM caps